Bosnalijek signed an agreement on long-term collaboration with the pharmaceutical company Imperia-Pharma from Russia for the gross value of 11,6 million euros.
This agreement provides the further placement of Bosnalijek products on the Russian market, and would contribute to the continuity of the business of Bosnalijek abroad.
Management of Bosnalijek, headed by Nedim Uzunović decided to establish cooperation with the company Imperia-Pharma, having in mind the fact that they are one of the biggest distributors of pharmaceutical products in Russia, and with its strong growth and experience could significantly contribute to improving the position of Bosnalijek on this important export market.
The agreement on cooperation with Imperia-Pharma was signed in accordance with the business strategy of Bosnalijek for 2013, and under the same conditions as other Russian distributors of Bosnalijek products.
(Source: Fena)
